694 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Drug Stocks Q1 Earnings Releases on Apr 25: LLY, BIIB, NVS http://www.zacks.com/stock/news/257367/drug-stocks-q1-earnings-releases-on-apr-25-lly-biib-nvs?cid=CS-ZC-FT-257367 Apr 24, 2017 - As the Q1 earnings season gets in full swing this week, we believe this quarter is on track to see the highest growth in almost three years.
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease https://www.wsj.com/articles/novartis-tests-new-alzheimers-drug-on-people-who-dont-have-the-disease-1492871315?mod=pls_whats_news_us_business_f Apr 23, 2017 - Subjects at high risk of developing Alzheimer’s—but who don’t actually have the disease—are being recruited to help test two experimental treatments from Novartis AG, in a new focus on preventive treatment.
Read This Before You Buy Biotech Stocks https://www.fool.com/investing/2017/04/23/read-this-before-you-buy-biotech-stocks.aspx?source=iedfolrf0000001 Apr 23, 2017 - Looking to buy biotech stocks? Here are 7 important things to know.
Earnings Growth Accelerates in Q1 http://www.zacks.com/commentary/111002/earnings-growth-accelerates-in-q1?cid=CS-ZC--111002 Apr 21, 2017 - Earnings Growth Accelerates in Q1
CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up http://www.zacks.com/stock/news/257137/cytrx-gets-clarity-from-fda-for-aldoxorubicin-nda-shares-up?cid=CS-ZC-FT-257137 Apr 20, 2017 - CytRx Corporation (CYTR) announced that the it has reached an agreement with the regarding the path to filing for its new drug application (NDA) for its lead candidate aldoxorubicin being developed for the treatment of soft tissue sarcomas (STS).
This $26 Billion Company Is the Market's Most Overpriced Biotech Stock https://www.fool.com/investing/2017/04/20/this-26-billion-company-is-the-markets-most-overpr.aspx?source=iedfolrf0000001 Apr 20, 2017 - Nearly 90% of this biotech's sales could be at risk within the next two years.
Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards? http://www.zacks.com/stock/news/257090/eli-lilly-lly-to-report-q1-earnings-whats-in-the-cards?cid=CS-ZC-FT-257090 Apr 20, 2017 - Eli Lilly and Company (LLY) will report first-quarter 2017 results on Apr 25, before the market opens.
The 4 Best Dividend Stocks in Pharmaceuticals https://www.fool.com/investing/2017/04/18/the-4-best-dividend-stocks-in-pharmaceuticals.aspx?source=iedfolrf0000001 Apr 18, 2017 - Find out how these pharma stocks could boost your dividend growth portfolio’s performance.
Company News for April 18, 2017 http://www.zacks.com/stock/news/256727/company-news-for-april-18-2017?cid=CS-ZC-FT-256727 Apr 18, 2017 - Companies in the News are: MGI,LLY,ASH,ALR,ABT
What Happened in the Stock Market Today https://www.fool.com/investing/2017/04/17/what-happened-in-the-stock-market-today.aspx?source=iedfolrf0000001 Apr 18, 2017 - Drugmakers get denied, Chipotle continues gains, and earnings season gets under way. Investors have remained optimistic ahead of what could be a tumultuous week.

Pages: 1...5859606162636465666768...70

<<<Page 63>